These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunological studies on malignant melanomas of man. Romsdahl MM; Cox IS Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125 [No Abstract] [Full Text] [Related]
7. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas. Gupta RK; Morton DL Cancer Res; 1975 Jan; 35(1):58-62. PubMed ID: 1109797 [TBL] [Abstract][Full Text] [Related]
9. Blocking factors against melanoma leucocyte-dependent antibody: relationship to disease activity in melanoma patients. Hersey P; Murray E; Ruygrok S; Edwards A; Milton GW Aust N Z J Surg; 1978 Feb; 48(1):26-32. PubMed ID: 276346 [TBL] [Abstract][Full Text] [Related]
10. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens. McCabe RP; Quaranta V; Frugis L; Ferrone S; Reisfeld RA J Natl Cancer Inst; 1979 Mar; 62(3):455-63. PubMed ID: 283276 [TBL] [Abstract][Full Text] [Related]
11. The cell-mediated immunity in patients with malignant melanoma. Fixa B; Komárková O; Kraus Z; Simková H Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654 [TBL] [Abstract][Full Text] [Related]
13. Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients. Murray E; Ruygrok S; Milton GW; Hersey P Int J Cancer; 1978 May; 21(5):578-87. PubMed ID: 350780 [No Abstract] [Full Text] [Related]
14. Report of the immunology working party of the EORTC melanoma group. Rümke P Eur J Cancer Clin Oncol; 1981 Jul; 17(7):839-41. PubMed ID: 7037425 [No Abstract] [Full Text] [Related]
15. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects. Luo W; Ko E; Hsu JC; Wang X; Ferrone S J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313 [TBL] [Abstract][Full Text] [Related]
16. Immunological associations of the halo naevus with cutaneous malignant melanoma. Copeman PW; Lewis MG; Phillips TM; Elliott PG Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770 [No Abstract] [Full Text] [Related]
17. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells. Leong SP; Sutherland CM; Krementz ET Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343 [No Abstract] [Full Text] [Related]
18. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas. Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354 [TBL] [Abstract][Full Text] [Related]